RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance

Patients with metastatic castration-resistant prostate cancer (mCRPC) develop resistance to conventional therapies including docetaxel (DTX). Identifying molecular pathways underlying DTX resistance is critical for developing novel combinatorial therapies to prevent or reverse this resistance. To id...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Cajigas-Du Ross, Christina K., Martinez, Shannalee R., Woods-Burnham, Leanne, Durán, Alfonso M., Roy, Sourav, Basu, Anamika, Ramirez, Joshua A., Ortiz-Hernández, Greisha L., Ríos-Colón, Leslimar, Chirshev, Evgeny, Sanchez-Hernandez, Evelyn S., Soto, Ubaldo, Greco, Celine, Boucheix, Claude, Chen, Xin, Unternaehrer, Juli, Wang, Charles, Casiano, Carlos A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2018
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084384/
https://ncbi.nlm.nih.gov/pubmed/30100995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25744
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk